387 related articles for article (PubMed ID: 10510170)
1. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
Arvanov VL; Liang X; Russo A; Wang RY
Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
[TBL] [Abstract][Full Text] [Related]
2. A pre- and postsynaptic modulatory action of 5-HT and the 5-HT2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex.
Arvanov VL; Liang X; Magro P; Roberts R; Wang RY
Eur J Neurosci; 1999 Aug; 11(8):2917-34. PubMed ID: 10457188
[TBL] [Abstract][Full Text] [Related]
3. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
4. Tolerance to LSD and DOB induced shaking behaviour: differential adaptations of frontocortical 5-HT(2A) and glutamate receptor binding sites.
Buchborn T; Schröder H; Dieterich DC; Grecksch G; Höllt V
Behav Brain Res; 2015 Mar; 281():62-8. PubMed ID: 25513973
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
Schindler EA; Harvey JA; Aloyo VJ
Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NMDA-receptor mediated response in the rat medial prefrontal cortical pyramidal cells by the 5-HT3 receptor agonist SR 57227A and 5-HT: intracellular studies.
Liang X; Arvanov VL; Wang RY
Synapse; 1998 Jul; 29(3):257-68. PubMed ID: 9635896
[TBL] [Abstract][Full Text] [Related]
7. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice.
Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E
Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221
[TBL] [Abstract][Full Text] [Related]
8. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
Arvanov VL; Wang RY
Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.
Pierce PA; Peroutka SJ
J Pharmacol Exp Ther; 1988 Dec; 247(3):918-25. PubMed ID: 3204523
[TBL] [Abstract][Full Text] [Related]
10. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
[TBL] [Abstract][Full Text] [Related]
11. Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex.
Stutzmann GE; Marek GJ; Aghajanian GK
Neuroscience; 2001; 105(1):55-69. PubMed ID: 11483300
[TBL] [Abstract][Full Text] [Related]
12. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats.
Willins DL; Meltzer HY
J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333
[TBL] [Abstract][Full Text] [Related]
13. Lysergic acid diethylamide and [-]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex.
Muschamp JW; Regina MJ; Hull EM; Winter JC; Rabin RA
Brain Res; 2004 Oct; 1023(1):134-40. PubMed ID: 15364028
[TBL] [Abstract][Full Text] [Related]
14. A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex.
Marek GJ; Wright RA; Gewirtz JC; Schoepp DD
Neuroscience; 2001; 105(2):379-92. PubMed ID: 11672605
[TBL] [Abstract][Full Text] [Related]
15. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.
Martín-Ruiz R; Puig MV; Celada P; Shapiro DA; Roth BL; Mengod G; Artigas F
J Neurosci; 2001 Dec; 21(24):9856-66. PubMed ID: 11739593
[TBL] [Abstract][Full Text] [Related]
16. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
Sanders-Bush E; Burris KD; Knoth K
J Pharmacol Exp Ther; 1988 Sep; 246(3):924-8. PubMed ID: 2843634
[TBL] [Abstract][Full Text] [Related]
17. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
18. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.
Aghajanian GK; Marek GJ
Brain Res; 1999 Apr; 825(1-2):161-71. PubMed ID: 10216183
[TBL] [Abstract][Full Text] [Related]
19. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
Titeler M; Lyon RA; Glennon RA
Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
[TBL] [Abstract][Full Text] [Related]
20. Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al.
Romano AG; Quinn JL; Li L; Dave KD; Schindler EA; Aloyo VJ; Harvey JA
Psychopharmacology (Berl); 2010 Oct; 212(3):441-8. PubMed ID: 20827462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
